menu
    • menu

    Company profile for Cardiol Therapeutics

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Cardiol Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease. The Company brings together a wealth of research and development experience, advanced manufacturing capabilities, and a Management team, Board of Directors, and Scientific Advisory Board comprising business and thought leaders with extensive industry experience and expertise in commercializi...
    Cardiol Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies for inflammatory heart disease. The Company brings together a wealth of research and development experience, advanced manufacturing capabilities, and a Management team, Board of Directors, and Scientific Advisory Board comprising business and thought leaders with extensive industry experience and expertise in commercializing proprietary drugs. Cardiol recently received approval from the U.S. FDA for its Investigational New Drug (IND) application to commence a Phase II/III, double-blind, etc

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Cardiol TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    2265 Upper Middle Road East, Suite 602 Oakville, ON L6H 0G5
    Telephone
    Telephone
    289.910.0850
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cardiolrx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cardiolrx/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/cardiolrx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cardiol Therapeutics Secures US Patent For Heart Disease Drug
    Cardiol Therapeutics Secures US Patent For Heart Disease Drug

    19 Nov 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/cardiol-therapeutics-wins-us-patent-protection-for-heart-disease-drug-platform-18278

    INDPHARMAPOST
    19 Nov 2025
    Share Share
    Cardiol's CRD-38 May Stand Out In Heart Failure Space: GlobalData
    Cardiol's CRD-38 May Stand Out In Heart Failure Space: GlobalData

    02 Mar 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/cardiols-crd-38-holds-potential-to-differentiate-in-hf-space-globaldata/

    EXPRESSPHARMA
    02 Mar 2025
    Share Share
    Hope On The Horizon: MAvERIC-Pilot Shows Heartfelt Progress For Patients
    Hope On The Horizon: MAvERIC-Pilot Shows Heartfelt Progress For Patients

    17 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=877924&lang=en

    ACCESSWIRE
    17 Jun 2024
    Share Share
    Cardiol begins subject enrolment in recurrent pericarditis trial
    Cardiol begins subject enrolment in recurrent pericarditis trial

    18 Jan 2023

    // CLINICAL TRIALS ARENA

    https://www.clinicaltrialsarena.com/news/cardiol-recurrent-pericarditis-trial/

    CLINICAL TRIALS ARENA
    18 Jan 2023
    Share Share
    Cardiol Therapeutics Announces Pre-Clinical Study Demonstrating CardiolRx
    Cardiol Therapeutics Announces Pre-Clinical Study Demonstrating CardiolRx

    03 Oct 2022

    // BIOSPACE

    https://www.biospace.com/article/cardiol-therapeutics-announces-pre-clinical-study-results-demonstrating-cardiolrx-tm-inhibits-and-also-promotes-reversal-of-mechanisms-leading-to-cardiac-fibrosis/

    BIOSPACE
    03 Oct 2022
    Share Share
    Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed PO
    Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed PO

    02 Nov 2021

    // NEWSWISE

    https://www.newswire.ca/news-releases/cardiol-therapeutics-files-preliminary-prospectus-supplement-for-proposed-public-offering-of-units-876229890.html

    NEWSWISE
    02 Nov 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search